查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1803737

全球甲烷减量疫苗市场（依疫苗技术、动物种类、配送途径及最终用户划分）－2025 年至 2030 年预测

Methane Mitigation Vaccine Market by Vaccine Technology, Animal Type, Delivery Route, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年甲烷减量疫苗市场价值为 1,812 万美元，预计 2025 年将成长至 1,942 万美元，复合年增长率为 7.42%，到 2030 年将达到 2,785 万美元。

主要市场统计数据
基准年2024年 1812万美元
预计2025年 1942万美元
预测年份 2030 2785万美元
复合年增长率（%） 7.42%

引入针对疫苗特定甲烷排放的生物策略，以增强畜牧业的永续性和生态系统保护

反刍动物养殖是全球农业的基石，但其肠道发酵对人类活动排放贡献巨大。在这些排放气体中，甲烷因其可能导致短期气候变暖而引人注目。随着全球监管机构收紧环境标准，消费者对永续性的需求不断提升，农业部门面临越来越大的创新压力。在此背景下，旨在抑制牲畜甲烷产生的疫苗应运而生，成为一种突破性的解决方案，有望在生产力与环境管理之间取得平衡。

评估不断变化的监管、技术和市场动态，塑造畜牧业生产中甲烷减量疫苗的前景

监管、技术和市场力量的融合正在重塑减少甲烷排放的疫苗接种格局。在监管方面，新兴经济体政府正在製定严格的农业温室气体减量目标。这些政策趋势正在刺激公共资金和私人投资于新型疫苗平台。同时，重组DNA技术和抗原设计的进步使得针对瘤胃产甲烷菌的精准度达到新的水平，从而提高了疫苗的有效性和安全性。

分析2025年美国关税对减少甲烷疫苗研发和供应链的深远影响

美国于2025年征收的新关税对整个减少甲烷排放的疫苗供应链产生了连锁反应。透过提高进口生技药品、实验室试剂和专用佐剂的关税，这些措施增加了依赖全球采购网路的疫苗开发商的生产成本。结果，海外生产设施不得不迁移或建立本地生产能力以规避关税壁垒，这迫使它们调整投资策略和物流计划。

透过按技术、动物种类、配送途径和最终用户细分的关键洞察，揭示甲烷疫苗市场动态

全面的細項分析揭示了技术平台、牲畜品种、交付方式和最终用户需求方面存在的独特机会和挑战。就疫苗技术而言，基于抗原的方法提供了具有成熟生产能力的传统途径，而重组DNA疫苗则具有更高的特异性和快速的规模化生产能力。这些不同的特性有助于指导研究投资和生产计画的策略决策。

探索美洲、中东和非洲以及亚太地区甲烷减量疫苗的区域前景和机会

区域分析突显了不同的政策框架、研究能力和市场奖励如何影响美洲、欧洲、中东和非洲地区以及亚太地区的疫苗采用轨迹。在美洲，监管机构正在北美推出试验计画，为早期商业试验津贴；而拉丁美洲的研究中心则与全球合作伙伴合作，在热带牧场系统中检验疫苗有效性。这些努力充分利用了强大的兽医网络和稳健的农业相关企业链。

介绍塑造全球甲烷减量疫苗解决方案竞争格局的领先开发商和策略联盟

产业领导者和新兴生物技术公司正在组建策略联盟，以加速疫苗的开发和商业化。一些知名动物用药品公司已与专注于黏膜免疫学和抗原工程的新兴生物技术新兴企业签订了授权合约。这些联盟将尖端的科学专业知识与成熟的生产和分销网络相结合。

为产业领导者提供可行的策略和指导，以利用畜牧业生产中新兴的甲烷减量疫苗机会

为了抓住新兴疫苗机会，产业决策者应优先建立本地生产能力，以降低贸易相关风险并增强供应链韧性。与政府机构进行策略合作可以释放奖励，简化监管途径，并加速市场进入。同时，将研发工作与农场检验计画结合，可以提高产品可信度，并产生真实世界的有效性数据，从而推动疫苗的推广应用。

我们详细介绍了一个强大的调查方法框架，该框架结合了二手研究、专家咨询和数据三角测量，以进行深入的疫苗格局分析。

为了确保研究结果的可靠性，该报告采用了全面、全面的方法，基于广泛的二手调查方法，包括同行评审的科学文章、监管文件、专利资料库和行业白皮书，为疫苗开发建立了技术和监管背景。

综合主要发现和策略意义，总结减少甲烷的疫苗在永续畜牧业管理中的重要作用

综上所述，减少甲烷排放疫苗的出现代表着永续畜牧业管理的关键进展。这些生物干预措施直接针对肠道产甲烷菌，为现有的减排策略提供了新的补充，有望大幅减少反刍动物生产的碳排放。不断变化的法规环境，加上强大的市场奖励，正在活性化跨地区、跨组织类型的研究与合作。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 成本效益分析模型评估甲烷抑制疫苗的长期经济影响
  • 重组疫苗输送系统在减少牛肠道甲烷的研究进展
  • 牲畜甲烷抑制疫苗面临的监管核准途径和合规挑战
  • 生技公司与农业合作社合作进行甲烷疫苗现场测试
  • 消费者和零售商对乳製品和牛肉品牌的压力推动了减少甲烷疫苗的采用

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. 甲烷减量疫苗市场疫苗技术

  • 抗原疫苗
  • 重组DNA疫苗

9. 甲烷减量疫苗市场（依动物种类）

  • 水牛
  • 牛
  • 山羊
  • 羊

第十章 甲烷减量疫苗市场（依运输途径）

  • 注射
    • 肌肉注射
    • 皮下
  • 口服

第 11 章甲烷减量疫苗市场（以最终用户划分）

  • 商业农场
  • 研究机构

12. 美国甲烷减量疫苗市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 欧洲、中东和非洲甲烷减量疫苗市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

14. 亚太地区甲烷减量疫苗市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • ArkeaBio Inc.
    • Lucidome Bio Ltd.
    • AgResearch Ltd.
    • AgriZero NZ Ltd.
    • Zoetis Inc. by Pfizer Inc.

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-B02FEF845EA7

The Methane Mitigation Vaccine Market was valued at USD 18.12 million in 2024 and is projected to grow to USD 19.42 million in 2025, with a CAGR of 7.42%, reaching USD 27.85 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 18.12 million
Estimated Year [2025] USD 19.42 million
Forecast Year [2030] USD 27.85 million
CAGR (%) 7.42%

Introducing a Biological Strategy to Target Methane Emissions through Vaccine Innovations for Enhanced Livestock Sustainability and Ecosystem Protection

Ruminant livestock production is a cornerstone of global agriculture, yet it contributes significantly to anthropogenic greenhouse gas emissions through enteric fermentation. Among these emissions, methane stands out for its potency in driving near-term climate warming. As regulatory bodies worldwide tighten environmental standards and consumers demand greater sustainability credentials, the agricultural sector faces mounting pressure to innovate. In this context, a vaccine designed to mitigate methane production in livestock emerges as a game-changing solution that promises to reconcile productivity with environmental stewardship.

This approach harnesses advances in immunology and microbiology to stimulate specific immune responses against methanogenic archaea in the rumen, reducing methane output at its source. Early research has demonstrated promising immunogenic profiles, and ongoing studies are refining antigen selection and delivery mechanisms to optimize efficacy across diverse animal populations. Moreover, this technology aligns with broader decarbonization efforts in agriculture by offering a scalable intervention that complements feed additives and management practices. Consequently, stakeholders across the value chain-from breeders and feed producers to regulatory agencies-are collaborating to accelerate development and validation. Ultimately, this innovative vaccine strategy stands to redefine sustainable livestock management, transforming methane mitigation from a reactive measure into a proactive, science-driven pathway.

Assessing the Transformation Driven by Regulatory, Technological, and Market Dynamics Shaping the Methane Mitigation Vaccine Landscape in Livestock Production

The landscape of methane mitigation vaccination is being reshaped by a convergence of regulatory, technological, and market forces. On the regulatory front, governments in developed economies are establishing stringent targets for agricultural greenhouse gas reductions. This policy trajectory has spurred public funding initiatives and incentivized private investment into novel vaccine platforms. Simultaneously, advances in recombinant DNA technology and antigen design are unlocking new levels of precision in targeting ruminal methanogens, enhancing both efficacy and safety profiles.

Market dynamics are also shifting in favor of preventative approaches. Corporations and cooperatives are increasingly integrating sustainability metrics into procurement and sourcing strategies, creating premium value chains for low-emission livestock products. This demand signal has, in turn, prompted biotechnology firms and animal health companies to prioritize methane mitigation in their innovation pipelines. Moreover, collaborative consortia involving academic institutions, agritech startups, and public research bodies are facilitating knowledge exchange and de-risking early-stage development. As a result, the methane mitigation vaccine landscape is transitioning from fragmented proof-of-concept efforts to coordinated, large-scale R&D endeavors. These transformative shifts are laying the groundwork for faster commercialization pathways and broader adoption once regulatory approvals are secured.

Analyzing the Far-Reaching Consequences of United States Tariffs Implemented in 2025 on Methane Mitigation Vaccine Development and Supply Chains

The imposition of new tariffs by the United States in 2025 has produced a ripple effect across the methane mitigation vaccine supply chain. By raising duties on imported biologics, laboratory reagents, and specialized adjuvants, these measures have increased production costs for vaccine developers reliant on global procurement networks. Consequently, manufacturing facilities based outside the country have faced pressure to relocate or establish local capacity to avoid tariff barriers, driving shifts in investment strategies and logistical planning.

Furthermore, increased import costs have impelled both research institutions and commercial producers to reevaluate their sourcing strategies. Some stakeholders are exploring domestic production of critical raw materials, while others are pursuing alternative reagents that bypass tariff classifications. Although these adaptations require renegotiated supplier contracts and validation of substitute inputs, they ultimately contribute to strengthening regional resilience and reducing dependency on external markets. At the same time, the higher cost environment highlights the need for streamlined regulatory approvals and targeted incentives to offset the financial burden. As a result, industry players are collaborating with policymakers to design tariff mitigation programs and subsidy frameworks that sustain innovation momentum. Through these collective efforts, the vaccine development ecosystem continues to advance despite evolving trade constraints.

Deriving Critical Insights from Segmentation by Technology, Animal Type, Delivery Route, and End User to Illuminate Methane Vaccine Market Dynamics

A thorough segmentation analysis reveals distinct opportunities and challenges across technology platforms, livestock species, delivery methods, and end-user requirements. When examined by vaccine technology, antigen-based approaches offer a traditional pathway with a well-established manufacturing base, while recombinant DNA vaccines deliver enhanced specificity and potential for rapid scale-up. These differing attributes inform strategic decisions for research investment and production planning.

In terms of animal categories, buffalo and cattle represent the largest sources of enteric methane, necessitating tailored immunization protocols that account for species-specific rumen microbiota and immune responses. Smaller ruminants such as goats and sheep, although contributing a smaller absolute volume of emissions, present unique biological and operational contexts that influence dosing regimens and vaccine formulation priorities.

Delivery routes add another layer of complexity. Injectable vaccines, whether administered intramuscularly or subcutaneously, can achieve robust antigen presentation but require veterinary expertise and handling infrastructure. Oral vaccines, by contrast, offer ease of administration and the potential for integration into feed or bolus systems, though they must overcome barriers such as antigen degradation in the gastrointestinal tract.

Finally, segmenting by end users distinguishes commercial farming operations focused on large-scale deployment and cost efficiencies from research institutions advancing novel formulations and conducting foundational trials. Recognizing these divergent needs enables developers to align product design with market adoption pathways and to calibrate engagement strategies accordingly.

Exploring Regional Perspectives and Opportunities in the Americas, Europe Middle East and Africa, and Asia-Pacific for Methane Mitigation Vaccines

Regional analyses underscore how diverse policy frameworks, research capacities, and market incentives shape adoption trajectories across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, regulatory agencies have launched pilot programs in North America that subsidize early commercial trials, while Latin American research centers collaborate with global partners to validate vaccine efficacy under tropical grazing systems. These initiatives leverage strong veterinary networks and robust agribusiness supply chains.

Across Europe, Middle East and Africa, stringent climate targets in the European Union are driving substantial grant funding for translational research, with major field trials scheduled in collaboration with key agricultural cooperatives. Emerging markets in the Middle East and Africa are positioning themselves as manufacturing hubs for biologics, attracting foreign direct investment and technology licensing agreements. These developments reflect an increasing emphasis on regional self-reliance and export potential.

In the Asia-Pacific region, countries such as Australia and New Zealand, with advanced livestock industries and progressive environmental mandates, are conducting comprehensive efficacy studies that integrate methane measurements with productivity assessments. Meanwhile, research institutes in East Asia are exploring novel adjuvant systems and delivery technologies to optimize stability in varied climatic conditions. These regional initiatives collectively contribute to a global mosaic of innovation, each informed by local priorities and ecosystems.

Highlighting Leading Developers and Strategic Collaborations Shaping the Competitive Landscape of Methane Mitigation Vaccine Solutions Globally

Industry leaders and emerging biotechs are forging strategic partnerships to accelerate vaccine development and commercialization. Several established animal health companies have entered licensing agreements with biotech startups specializing in mucosal immunology and antigen engineering. These collaborations enable the integration of cutting-edge scientific expertise with established manufacturing and distribution networks.

At the same time, contract research organizations are expanding their service portfolios to include specialized assay development for methane-specific immunoassays, while strategic alliances between academic consortia and private funders are underwriting large-scale field evaluations. Intellectual property landscapes are evolving rapidly, with key patents covering innovative antigen constructs and adjuvant formulations. Additionally, venture capital firms are increasing allocations to sustainable agritech ventures, signaling confidence in greenhouse-gas-focused solutions.

As a result, the competitive landscape is characterized by a blend of horizontal consolidation among large animal health players and vertical integration by nimble startups that encompass end-to-end vaccine design, production, and delivery. This dynamic environment underscores the importance of proactive IP management, robust supply chain strategies, and continuous engagement with regulatory stakeholders to maintain leadership positions.

Offering Actionable Strategies and Guidance for Industry Leaders to Capitalize on Emerging Methane Mitigation Vaccine Opportunities in Livestock

To capitalize on emerging vaccine opportunities, industry decision-makers should prioritize the establishment of localized manufacturing capacity that mitigates trade-related risks and enhances supply chain resilience. Strategic engagement with government agencies can unlock incentives and streamline regulatory pathways, enabling faster market entry. Meanwhile, aligning R&D efforts with on-farm validation programs will generate real-world efficacy data that strengthen product credibility and support adoption.

Furthermore, forging cross-sector alliances with feed additive producers and livestock integrators can create bundled value propositions that resonate with end users seeking holistic emission-reduction solutions. Investing in scalable delivery platforms-such as oral formulations compatible with automated dosing systems-will reduce operational complexity for commercial farming enterprises. At the same time, aligning product development with certification schemes and sustainability metrics can unlock premium pricing opportunities within eco-conscious supply chains.

Finally, maintaining an agile innovation pipeline that incorporates iterative feedback from research partnerships and pilot deployments will ensure continuous improvement. By adopting these strategic measures, industry leaders can secure a competitive edge and drive widespread adoption of methane mitigation vaccines.

Detailing a Robust Methodological Framework Combining Secondary Research, Expert Consultations, and Data Triangulation for In-Depth Vaccine Landscape Analysis

This report employs a comprehensive methodology that integrates multiple research techniques to ensure the robustness of its findings. A foundational step involves extensive secondary research, including peer-reviewed scientific publications, regulatory filings, patent databases, and industry white papers. This phase establishes the technological and regulatory context for vaccine development.

Complementing secondary insights, structured interviews were conducted with leading experts in veterinary immunology, environmental science, and agricultural policy. These consultations provide qualitative depth, uncovering real-world challenges in vaccine deployment and highlighting best practices from early-stage field trials. Data triangulation further refines conclusions by cross-referencing quantitative metrics with anecdotal evidence from pilot programs and case studies.

To validate the research framework, a series of workshops with stakeholders-ranging from commercial farmers to contract manufacturers-was held to test assumptions and prioritize strategic recommendations. Throughout the process, rigorous quality-assurance protocols were applied to ensure consistency, reduce bias, and maintain transparency. This integrated approach guarantees that the analysis reflects both empirical rigor and actionable industry insights.

Synthesizing Key Findings and Strategic Implications to Conclude the Critical Role of Methane Mitigation Vaccines in Sustainable Livestock Management

In synthesis, the emergence of methane mitigation vaccines represents a pivotal advancement in sustainable livestock management. By targeting enteric methanogens directly, these biological interventions offer a novel complement to existing mitigation measures, with the potential to dramatically lower the carbon footprint of ruminant production. The evolving regulatory environment, coupled with strong market incentives, has galvanized research and collaboration across multiple geographies and organizational types.

The cumulative impact of recent trade policies, segmentation dynamics, and regional initiatives underscores the complexity and interdependence of the innovation ecosystem. However, proactive strategies-such as localizing production, fostering public-private partnerships, and aligning with sustainability frameworks-can address these challenges and accelerate adoption. As key players refine their competitive positioning through strategic alliances and IP management, the pathway to commercialization becomes clearer.

Ultimately, the successful deployment of methane mitigation vaccines hinges on coordinated efforts among developers, regulators, end users, and investors. This report has synthesized critical insights to guide stakeholders in navigating this emerging field, laying the foundation for transformative environmental and economic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Cost-benefit analysis models assessing long term economic impact of methane mitigation vaccines
  • 5.2. Advancements in recombinant vaccine delivery systems for enteric methane reduction in cattle herds
  • 5.3. Regulatory approval pathways and compliance challenges facing livestock methane mitigation vaccines
  • 5.4. Collaborations between biotech firms and agricultural cooperatives for methane vaccine field trials
  • 5.5. Consumer and retailer pressure on dairy and beef brands driving adoption of methane reduction vaccines

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Methane Mitigation Vaccine Market, by Vaccine Technology

  • 8.1. Introduction
  • 8.2. Antigen-Based Vaccines
  • 8.3. Recombinant DNA Vaccines

9. Methane Mitigation Vaccine Market, by Animal Type

  • 9.1. Introduction
  • 9.2. Buffalo
  • 9.3. Cattle
  • 9.4. Goat
  • 9.5. Sheep

10. Methane Mitigation Vaccine Market, by Delivery Route

  • 10.1. Introduction
  • 10.2. Injectable
    • 10.2.1. Intramuscular
    • 10.2.2. Subcutaneous
  • 10.3. Oral

11. Methane Mitigation Vaccine Market, by End User

  • 11.1. Introduction
  • 11.2. Commercial Farms
  • 11.3. Research Institutions

12. Americas Methane Mitigation Vaccine Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Methane Mitigation Vaccine Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Methane Mitigation Vaccine Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. ArkeaBio Inc.
    • 15.3.2. Lucidome Bio Ltd.
    • 15.3.3. AgResearch Ltd.
    • 15.3.4. AgriZero NZ Ltd.
    • 15.3.5. Zoetis Inc. by Pfizer Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. METHANE MITIGATION VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. METHANE MITIGATION VACCINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. METHANE MITIGATION VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. METHANE MITIGATION VACCINE MARKET: RESEARCHAI
  • FIGURE 24. METHANE MITIGATION VACCINE MARKET: RESEARCHSTATISTICS
  • FIGURE 25. METHANE MITIGATION VACCINE MARKET: RESEARCHCONTACTS
  • FIGURE 26. METHANE MITIGATION VACCINE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. METHANE MITIGATION VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY ANTIGEN-BASED VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY ANTIGEN-BASED VACCINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY RECOMBINANT DNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY RECOMBINANT DNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY BUFFALO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY BUFFALO, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY GOAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY GOAT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY SHEEP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY SHEEP, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL METHANE MITIGATION VACCINE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 44. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 45. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 47. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 48. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 49. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 50. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 51. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 52. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 53. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. AMERICAS METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 55. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 56. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 57. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 58. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 59. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 60. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 61. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 62. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 63. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 64. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 65. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 66. UNITED STATES METHANE MITIGATION VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 67. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 69. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 70. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 71. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 72. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 73. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 74. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 75. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 76. CANADA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 77. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 78. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 79. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 81. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 82. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 83. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 84. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 85. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. MEXICO METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 87. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 88. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 89. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 91. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 92. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 93. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 94. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 95. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. BRAZIL METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 97. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 99. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 102. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 103. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 104. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 105. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. ARGENTINA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED KINGDOM METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 129. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 131. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 133. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 134. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 135. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 136. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 137. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. GERMANY METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 139. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 141. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 143. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 144. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 145. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 146. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 147. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. FRANCE METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 149. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 151. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 154. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 155. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 156. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 157. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. RUSSIA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 159. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 161. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 164. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 165. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 166. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 167. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. ITALY METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 169. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 171. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 173. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 174. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 175. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 176. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 177. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. SPAIN METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 189. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 194. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 196. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. SAUDI ARABIA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 204. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 206. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. SOUTH AFRICA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 209. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 211. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 214. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 215. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 216. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 217. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. DENMARK METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 221. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 224. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 226. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. NETHERLANDS METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 229. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 231. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 234. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 235. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 236. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 237. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. QATAR METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 239. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 241. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 243. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 244. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 245. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 246. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 247. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. FINLAND METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 249. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 251. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 254. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 255. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 256. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 257. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. SWEDEN METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 259. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 264. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 265. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 266. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 267. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NIGERIA METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 269. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 270. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 271. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 274. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 275. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 276. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 277. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. EGYPT METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 281. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 284. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 285. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 286. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 287. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. TURKEY METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 289. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 290. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 291. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 293. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 294. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 295. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 296. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 297. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. ISRAEL METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 299. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 301. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 303. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 304. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 305. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 306. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 307. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. NORWAY METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 309. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 311. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 314. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 315. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
  • TABLE 316. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
  • TABLE 317. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. POLAND METHANE MITIGATION VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 319. SWITZERLAND METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. SWITZERLAND METHANE MITIGATION VACCINE MARKET SIZE, BY VACCINE TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 321. SWITZERLAND METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. SWITZERLAND METHANE MITIGATION VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 323. SWIT